DCF — ASPIRUS WAUSAU HOSPITAL
Enterprise Value: $81.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$81.1M
Enterprise Value
$7.2M
PV of Cash Flows
$73.9M
PV of Terminal Value
$119.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $665.1M | $24.0M | 4.0% | $-6.0M | $-5.4M |
| Year 2 | $685.1M | $31.6M | 5.0% | $-1.0M | $-0.8M |
| Year 3 | $705.6M | $39.6M | 6.0% | $4.2M | $3.2M |
| Year 4 | $726.8M | $44.4M | 6.0% | $7.1M | $4.8M |
| Year 5 | $748.6M | $47.6M | 6.0% | $8.7M | $5.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $81.1M. Terminal value accounts for 91% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$645.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.031125897528228932
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5